367 related articles for article (PubMed ID: 23948297)
21. [siRNA-mediated CDK6 knockdown suppresses nasopharyngeal carcinoma cell growth and cell cycle transition in vitro].
Luo X; Xia Q; Qin J; Huang Y; Liu J; Wang Y; Wang H; Chen J
Nan Fang Yi Ke Da Xue Xue Bao; 2014 Jun; 34(7):1071-4. PubMed ID: 25057088
[TBL] [Abstract][Full Text] [Related]
22. Modulated expression of genes encoding estrogen metabolizing enzymes by G1-phase cyclin-dependent kinases 6 and 4 in human breast cancer cells.
Jia Y; Domenico J; Swasey C; Wang M; Gelfand EW; Lucas JJ
PLoS One; 2014; 9(5):e97448. PubMed ID: 24848372
[TBL] [Abstract][Full Text] [Related]
23. MLL fusion-driven activation of CDK6 potentiates proliferation in MLL-rearranged infant ALL.
van der Linden MH; Willekes M; van Roon E; Seslija L; Schneider P; Pieters R; Stam RW
Cell Cycle; 2014; 13(5):834-44. PubMed ID: 24736461
[TBL] [Abstract][Full Text] [Related]
24. Baicalin suppresses the cell cycle progression and proliferation of prostate cancer cells through the CDK6/FOXM1 axis.
Yu Z; Zhan C; Du H; Zhang L; Liang C; Zhang L
Mol Cell Biochem; 2020 Jun; 469(1-2):169-178. PubMed ID: 32385718
[TBL] [Abstract][Full Text] [Related]
25. Requirement for CDK6 in MLL-rearranged acute myeloid leukemia.
Placke T; Faber K; Nonami A; Putwain SL; Salih HR; Heidel FH; Krämer A; Root DE; Barbie DA; Krivtsov AV; Armstrong SA; Hahn WC; Huntly BJ; Sykes SM; Milsom MD; Scholl C; Fröhling S
Blood; 2014 Jul; 124(1):13-23. PubMed ID: 24764564
[TBL] [Abstract][Full Text] [Related]
26. Induction of prolonged early G1 arrest by CDK4/CDK6 inhibition reprograms lymphoma cells for durable PI3Kδ inhibition through PIK3IP1.
Chiron D; Martin P; Di Liberto M; Huang X; Ely S; Lannutti BJ; Leonard JP; Mason CE; Chen-Kiang S
Cell Cycle; 2013 Jun; 12(12):1892-900. PubMed ID: 23676220
[TBL] [Abstract][Full Text] [Related]
27. c-JUN promotes BCR-ABL-induced lymphoid leukemia by inhibiting methylation of the 5' region of Cdk6.
Kollmann K; Heller G; Ott RG; Scheicher R; Zebedin-Brandl E; Schneckenleithner C; Simma O; Warsch W; Eckelhart E; Hoelbl A; Bilban M; Zöchbauer-Müller S; Malumbres M; Sexl V
Blood; 2011 Apr; 117(15):4065-75. PubMed ID: 21300982
[TBL] [Abstract][Full Text] [Related]
28. Notch signaling mediates G1/S cell-cycle progression in T cells via cyclin D3 and its dependent kinases.
Joshi I; Minter LM; Telfer J; Demarest RM; Capobianco AJ; Aster JC; Sicinski P; Fauq A; Golde TE; Osborne BA
Blood; 2009 Feb; 113(8):1689-98. PubMed ID: 19001083
[TBL] [Abstract][Full Text] [Related]
29. Targeting CDK6 in cancer: State of the art and new insights.
Tadesse S; Yu M; Kumarasiri M; Le BT; Wang S
Cell Cycle; 2015; 14(20):3220-30. PubMed ID: 26315616
[TBL] [Abstract][Full Text] [Related]
30. Forced expression of cyclin-dependent kinase 6 confers resistance of pro-B acute lymphocytic leukemia to Gleevec treatment.
Kuo TC; Chavarria-Smith JE; Huang D; Schlissel MS
Mol Cell Biol; 2011 Jul; 31(13):2566-76. PubMed ID: 21536647
[TBL] [Abstract][Full Text] [Related]
31. Circ_0058063 regulates CDK6 to promote bladder cancer progression by sponging miR-145-5p.
Sun M; Zhao W; Chen Z; Li M; Li S; Wu B; Bu R
J Cell Physiol; 2019 Apr; 234(4):4812-4824. PubMed ID: 30362519
[TBL] [Abstract][Full Text] [Related]
32. Bortezomib suppresses self-renewal and leukemogenesis of leukemia stem cell by NF-ĸB-dependent inhibition of CDK6 in MLL-rearranged myeloid leukemia.
Zhou B; Qin Y; Zhou J; Ruan J; Xiong F; Dong J; Huang X; Yu Z; Gao S
J Cell Mol Med; 2021 Mar; 25(6):3124-3135. PubMed ID: 33599085
[TBL] [Abstract][Full Text] [Related]
33. Cyclin independent role for cdk4/6 during B cell lymphoma survival.
Snow EC
Cell Cycle; 2010 Aug; 9(15):2932. PubMed ID: 20703096
[No Abstract] [Full Text] [Related]
34. p27 inhibits CDK6/CCND1 complex formation resulting in cell cycle arrest and inhibition of cell proliferation.
Li N; Zeng J; Sun F; Tong X; Meng G; Wu C; Ding X; Liu L; Han M; Lu C; Dai F
Cell Cycle; 2018; 17(19-20):2335-2348. PubMed ID: 30317923
[TBL] [Abstract][Full Text] [Related]
35. Cyclin-dependent kinase 6 phosphorylates NF-κB P65 at serine 536 and contributes to the regulation of inflammatory gene expression.
Buss H; Handschick K; Jurrmann N; Pekkonen P; Beuerlein K; Müller H; Wait R; Saklatvala J; Ojala PM; Schmitz ML; Naumann M; Kracht M
PLoS One; 2012; 7(12):e51847. PubMed ID: 23300567
[TBL] [Abstract][Full Text] [Related]
36. LncRNA LINC00974 Upregulates CDK6 to Promote Cell Cycle Progression in Gastric Carcinoma.
Gao H; Yin Y; Qian A; Guo R; Qi J
Cancer Biother Radiopharm; 2019 Dec; 34(10):666-670. PubMed ID: 31596614
[No Abstract] [Full Text] [Related]
37. Inhibition of cyclin-dependent kinase 6 suppresses cell proliferation and enhances radiation sensitivity in medulloblastoma cells.
Whiteway SL; Harris PS; Venkataraman S; Alimova I; Birks DK; Donson AM; Foreman NK; Vibhakar R
J Neurooncol; 2013 Jan; 111(2):113-21. PubMed ID: 23138228
[TBL] [Abstract][Full Text] [Related]
38. JunB is a gatekeeper for B-lymphoid leukemia.
Ott RG; Simma O; Kollmann K; Weisz E; Zebedin EM; Schorpp-Kistner M; Heller G; Zöchbauer S; Wagner EF; Freissmuth M; Sexl V
Oncogene; 2007 Jul; 26(33):4863-71. PubMed ID: 17297445
[TBL] [Abstract][Full Text] [Related]
39. Ablation of cdk4 and cdk6 affects proliferation of basal progenitor cells in the developing dorsal and ventral forebrain.
Grison A; Gaiser C; Bieder A; Baranek C; Atanasoski S
Dev Neurobiol; 2018 Jul; 78(7):660-670. PubMed ID: 29570951
[TBL] [Abstract][Full Text] [Related]
40. Fluorescent Peptide Biosensor for Probing CDK6 Kinase Activity in Lung Cancer Cell Extracts.
Soamalala J; Diot S; Pellerano M; Blanquart C; Galibert M; Jullian M; Puget K; Morris MC
Chembiochem; 2021 Mar; 22(6):1065-1071. PubMed ID: 33112024
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
